Company description

CDXC, or ChromaDex Corporation, is a publicly traded company with its headquarters in Irvine, California. The company is a science-based, consumer health and wellness company that focuses on developing and marketing nutraceutical products. CDXC is committed to improving the health and longevity of individuals through its innovative research and development of unique ingredient technologies. The company's primary business focuses on commercializing its proprietary nicotinamide riboside (NR) technology, which is used to create advanced dietary supplements and lifestyle products. CDXC operates through three business segments: Consumer Product, Ingredients, and Analytical reference standards. The Consumer Product segment sells TRU NIAGEN branded NR supplements, while the Ingredients segment supplies proprietary ingredients to consumer packaged goods companies. The Analytical reference standards segment manufactures and supplies phytochemical reference standards for research purposes, providing a source of revenue diversification for the company. CDXC has a global presence and has established partnerships with leading retailers, distributors, and manufacturers in various countries. With its strong emphasis on scientific research and innovation, CDXC continues to expand its product offerings and provide consumers with quality and reliable solutions for their health and wellness needs. As a leader in the nutraceutical industry, CDXC remains dedicated to improving the lives of individuals through its commitment to science-based, evidence-backed products.